[Iproniazid-induced acute hepatitis]

Area of Science:

• Hepatology
• Clinical Pharmacology
• Toxicology

Background:

• Drug-induced liver injury (DILI) is a significant clinical concern.
• Accurate diagnosis relies heavily on thorough patient history.
• Iproniazid, a monoamine-oxidase inhibitor, is known to cause severe acute hepatitis.

Observation:

• A case of acute hepatitis was observed.
• The patient had taken iproniazid.
• The drug is not available in Italy.

Findings:

• The observed hepatitis was confirmed to be iproniazid-induced.
• Despite the severity, the patient's condition showed a favorable outcome.
• Diagnostic process was guided by patient history.

Implications:

• This case highlights the importance of considering less common drugs in DILI diagnosis.
• Understanding drug-induced hepatitis is crucial for clinical practice.
• Prompt identification and management can lead to favorable outcomes in severe liver injury.